117 related articles for article (PubMed ID: 17526009)
41. Cytokine gene polymorphisms in heart transplantation: association of low IL-10 production genotype with Quilty effect.
Plaza DM; Fernández D; Builes M; Villegas A; García LF
J Heart Lung Transplant; 2003 Aug; 22(8):851-6. PubMed ID: 12909463
[TBL] [Abstract][Full Text] [Related]
42. Host genetics, steatosis and insulin resistance among African Americans and Caucasian Americans with hepatitis C virus genotype-1 infection.
Iuliano AD; Feingold E; Wahed AS; Kleiner DE; Belle SH; Conjeevaram HS; Zmuda J; Liang TJ; Yee LJ;
Intervirology; 2009; 52(1):49-56. PubMed ID: 19401628
[TBL] [Abstract][Full Text] [Related]
43. End-stage renal disease and African American race are independent predictors of mild liver fibrosis in patients with chronic hepatitis C infection.
Aslinia FM; Wasan SK; Mindikoglu AL; Adeyemo OA; Philosophe B; Drachenberg C; Howell CD
J Viral Hepat; 2012 May; 19(5):371-6. PubMed ID: 22497817
[TBL] [Abstract][Full Text] [Related]
44. Polymorphism of cytokine genes (TGF-beta1, IFN-gamma, IL-6, IL-10, and TNF-alpha) in patients with chronic pancreatitis.
Bendicho MT; Guedes JC; Silva NN; Santana GO; dos Santos RR; Lyra AC; Lyra LG; Meyer R; Lemaire DC
Pancreas; 2005 May; 30(4):333-6. PubMed ID: 15841043
[TBL] [Abstract][Full Text] [Related]
45. Transforming growth factor-beta1 gene polymorphisms are associated with progression of liver fibrosis in Caucasians with chronic hepatitis C infection.
Wang H; Mengsteab S; Tag CG; Gao CF; Hellerbrand C; Lammert F; Gressner AM; Weiskirchen R
World J Gastroenterol; 2005 Apr; 11(13):1929-36. PubMed ID: 15800982
[TBL] [Abstract][Full Text] [Related]
46. Transforming growth factor-beta-1 genetic polymorphism in Japanese patients with chronic hepatitis C virus infection.
Suzuki S; Tanaka Y; Orito E; Sugauchi F; Hasegawa I; Sakurai M; Fujiwara K; Ohno T; Ueda R; Mizokami M
J Gastroenterol Hepatol; 2003 Oct; 18(10):1139-43. PubMed ID: 12974899
[TBL] [Abstract][Full Text] [Related]
47. Gene polymorphisms of IL-10 and MxA in responders and non-responders to interferon therapy in HCV Egyptian patients genotype 4.
Shaker OG; Abdel-Rahim MT; Bayoumi ST
Cell Biochem Biophys; 2015 Mar; 71(2):617-25. PubMed ID: 25239021
[TBL] [Abstract][Full Text] [Related]
48. Interferon-γ and Interleukin-10 Gene Polymorphisms are not Predictors of Chronic Hepatitis C (Genotype-4) Disease Progression.
Bahgat NA; Kamal MM; Abdelaziz AO; Mohye MA; Shousha HI; ahmed MM; Elbaz TM; Nabil MM
Asian Pac J Cancer Prev; 2015; 16(12):5025-30. PubMed ID: 26163635
[TBL] [Abstract][Full Text] [Related]
49. Prevalence of
Świątek-Kościelna B; Kałużna E; Strauss E; Nowak J; Bereszyńska I; Gowin E; Wysocki J; Rembowska J; Barcińska D; Mozer-Lisewska I; Januszkiewicz-Lewandowska D
World J Gastroenterol; 2017 Jun; 23(21):3815-3824. PubMed ID: 28638221
[TBL] [Abstract][Full Text] [Related]
50. Single nucleotide polymorphism at exon 7 splice acceptor site of OAS1 gene determines response of hepatitis C virus patients to interferon therapy.
El Awady MK; Anany MA; Esmat G; Zayed N; Tabll AA; Helmy A; El Zayady AR; Abdalla MS; Sharada HM; El Raziky M; El Akel W; Abdalla S; Bader El Din NG
J Gastroenterol Hepatol; 2011 May; 26(5):843-50. PubMed ID: 21182542
[TBL] [Abstract][Full Text] [Related]
51. The hepatitis C virus NS5A protein and response to interferon alpha: mutational analyses in patients with chronic HCV genotype 3a infection from India.
Goyal A; Hofmann WP; Hermann E; Traver S; Hissar SS; Arora N; Blum HE; Zeuzem S; Sarrazin C; Sarin SK
Med Microbiol Immunol; 2007 Mar; 196(1):11-21. PubMed ID: 16955308
[TBL] [Abstract][Full Text] [Related]
52. Interleukin 10 polymorphisms as predictors of sustained response in antiviral therapy for chronic hepatitis C infection.
Yee LJ; Tang J; Gibson AW; Kimberly R; Van Leeuwen DJ; Kaslow RA
Hepatology; 2001 Mar; 33(3):708-12. PubMed ID: 11230752
[TBL] [Abstract][Full Text] [Related]
53. Impact of IL28B and
Domagalski K; Pawłowska M; Zaleśna A; Pilarczyk M; Rajewski P; Halota W; Tretyn A
World J Gastroenterol; 2016 Nov; 22(41):9186-9195. PubMed ID: 27895405
[TBL] [Abstract][Full Text] [Related]
54. Interleukin-6 haplotypes and the response to therapy of chronic hepatitis C virus infection.
Yee LJ; Im K; Borg B; Yang H; Liang TJ;
Genes Immun; 2009 Jun; 10(4):365-72. PubMed ID: 19387461
[TBL] [Abstract][Full Text] [Related]
55. Analysis of tumor necrosis factor-alpha, transforming growth factor-beta 1, interleukin-10, and interferon-gamma polymorphisms in patients with alcoholic chronic pancreatitis.
Schneider A; Barmada MM; Slivka A; Martin JA; Whitcomb DC
Alcohol; 2004 Jan; 32(1):19-24. PubMed ID: 15066699
[TBL] [Abstract][Full Text] [Related]
56. Transforming growth factor β1 polymorphisms and progression of graft fibrosis after liver transplantation for hepatitis C virus--induced liver disease.
Eurich D; Bahra M; Boas-Knoop S; Lock JF; Golembus J; Neuhaus R; Neuhaus P; Neumann UP
Liver Transpl; 2011 Mar; 17(3):279-88. PubMed ID: 21384510
[TBL] [Abstract][Full Text] [Related]
57. Comprehensive analysis for viral elements and interleukin-28B polymorphisms in response to pegylated interferon plus ribavirin therapy in hepatitis C virus 1B infection.
Maekawa S; Sakamoto M; Miura M; Kadokura M; Sueki R; Komase K; Shindo H; Komatsu N; Shindo K; Kanayama A; Ohmori T; Amemiya F; Takano S; Yamaguchi T; Nakayama Y; Kitamura T; Inoue T; Okada S; Enomoto N
Hepatology; 2012 Nov; 56(5):1611-21. PubMed ID: 22577043
[TBL] [Abstract][Full Text] [Related]
58. Polymorphism in the human major histocompatibility complex and early viral decline during treatment of chronic hepatitis C.
Yee LJ; Im K; Wahed AS; Bugawan T; Li J; Rhodes SL; Erlich H; Rosen HR; Liang TJ; Yang H;
Antimicrob Agents Chemother; 2009 Feb; 53(2):615-21. PubMed ID: 18852273
[TBL] [Abstract][Full Text] [Related]
59. Cytokine gene polymorphisms and serum cytokine levels in patients with idiopathic pulmonary fibrosis.
Alhamad EH; Cal JG; Shakoor Z; Almogren A; AlBoukai AA
BMC Med Genet; 2013 Jul; 14():66. PubMed ID: 23815594
[TBL] [Abstract][Full Text] [Related]
60. Effect of interleukin-10 gene promoter polymorphisms -1082 G/A and -592 C/A on response to therapy in children and adolescents with chronic hepatitis C virus infection.
El-Karaksy HM; Sharaf SA; Mandour IA; Mogahed EA; Rady NH; El-Mougy FA
Hum Immunol; 2016 Dec; 77(12):1248-1253. PubMed ID: 27660094
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
